Indicators of Response to the Wee1 Inhibitor Adavosertib in Acute Myeloid Leukemia

被引：0
|
作者：
Srivastava, Ankita [1 ]
Heckman, Caroline A. [1 ,2 ,3 ,4 ,5 ,6 ]
Miettinen, Juho Jalmari [3 ]
Harismendy, Olivier [7 ]
机构：
[1] Univ Helsinki, Inst Mol Med Finland FIMM, Helsinki, Finland
[2] Inst Mol Med Finland FIMM, Helsinki, Finland
[3] Univ Helsinki, Inst Mol Med Finland FIMM, Helsinki Inst Life Sci, Helsinki, Finland
[4] Univ Helsinki, Inst Mol Med Finland FIMM, Helsinki Inst Life Sci, ICAN Digital Precis Canc Med Flagship, Helsinki, Finland
[5] Univ Helsinki, Inst Mol Med Finland FIMM, HiLIFE, Helsinki, Finland
[6] Univ Helsinki, ICAN Digital Precis Canc Ctr Med Flagship, Helsinki, Finland
[7] Zentalis Pharmaceut, Translat Data Sci & Computat Biol, San Diego, CA USA
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-188608
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [21] A phase II study of cisplatin and the Wee1 inhibitor adavosertib in metastatic triple-negative breast cancer (mTNBC)
    Keenan, Tanya E.
    Tan-Wasielewski, Zhenying
    Trippa, Lorenzo
    Kochupurakkal, Bose
    Guerriero, Jennifer L.
    Tahara, Rie K.
    Winship, Grace
    Osmani, Wafa
    Andrews, Chelsea
    Conway, Jake R.
    He, Meng X.
    Pastorello, Ricardo
    Tracy, Adam
    Godin, Robert E.
    Overmoyer, Beth A.
    Winer, Eric P.
    Mittendorf, Elizabeth A.
    Shapiro, Geoffrey I.
    Van Allen, Eliezer M.
    Tolaney, Sara M.
    CANCER RESEARCH, 2020, 80 (04)
  • [22] Targeting WEE1 to enhance conventional therapies for acute lymphoblastic leukemia
    Di Rora, Andrea Ghelli Luserna
    Beeharry, Neil
    Imbrogno, Enrica
    Ferrari, Anna
    Robustelli, Valentina
    Righi, Simona
    Sabattini, Elena
    Falzacappa, Maria Vittoria Verga
    Ronchini, Chiara
    Testoni, Nicoletta
    Baldazzi, Carmen
    Papayannidis, Cristina
    Abbenante, Maria Chiara
    Marconi, Giovanni
    Paolini, Stefania
    Parisi, Sarah
    Sartor, Chiara
    Fontana, Maria Chiara
    De Matteis, Serena
    Iacobucci, Ilaria
    Pelicci, Pier Giuseppe
    Cavo, Michele
    Yen, Timothy J.
    Martinelli, Giovanni
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2018, 11
  • [23] Targeting WEE1 to enhance conventional therapies for acute lymphoblastic leukemia
    Andrea Ghelli Luserna Di Rorà
    Neil Beeharry
    Enrica Imbrogno
    Anna Ferrari
    Valentina Robustelli
    Simona Righi
    Elena Sabattini
    Maria Vittoria Verga Falzacappa
    Chiara Ronchini
    Nicoletta Testoni
    Carmen Baldazzi
    Cristina Papayannidis
    Maria Chiara Abbenante
    Giovanni Marconi
    Stefania Paolini
    Sarah Parisi
    Chiara Sartor
    Maria Chiara Fontana
    Serena De Matteis
    Ilaria Iacobucci
    Pier Giuseppe Pelicci
    Michele Cavo
    Timothy J. Yen
    Giovanni Martinelli
    Journal of Hematology & Oncology, 11
  • [24] Clinical Efficacy and Molecular Response Correlates of the WEE1 Inhibitor Adavosertib Combined with Cisplatin in Patients with Metastatic Triple-Negative Breast Cancer
    Keenan, Tanya E.
    Li, Tianyu
    Vallius, Tuulia
    Guerriero, Jennifer L.
    Tayob, Nabihah
    Kochupurakkal, Bose
    Davis, Janae
    Pastorello, Ricardo
    Tahara, Rie K.
    Anderson, Leilani
    Conway, Jake
    He, Meng X.
    Shannon, Erin
    Godin, Robert E.
    Sorger, Peter K.
    D'Andrea, Alan
    Overmoyer, Beth
    Winer, Eric P.
    Mittendorf, Elizabeth A.
    Van Allen, Eliezer M.
    Shapiro, Geoffrey, I
    Tolaney, Sara M.
    CLINICAL CANCER RESEARCH, 2021, 27 (04) : 983 - 991
  • [25] Multicenter Phase II Trial of the WEE1 Inhibitor Adavosertib in Refractory Solid Tumors Harboring CCNE1 Amplification
    Fu, Siqing
    Yao, Shuyang
    Yuan, Yuan
    Previs, Rebecca A.
    Elias, Anthony D.
    Carvajal, Richard D.
    George, Thomas J.
    Yuan, Ying
    Yu, Lihou
    Westin, Shannon N.
    Xing, Yan
    Dumbrava, Ecaterina E.
    Karp, Daniel D.
    Piha-Paul, Sarina A.
    Tsimberidou, Apostolia M.
    Ahnert, Jordi Rodon
    Takebe, Naoko
    Lu, Karen
    Keyomarsi, Khandan
    Meric-Bernstam, Funda
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (09) : 1725 - +
  • [26] Phase II trial of the Wee1 inhibitor adavosertib in advanced refractory solid tumors with CCNE1 amplification.
    Fu, Siqing
    Yao, Shuyang
    Yuan, Yuan
    Previs, Rebecca A.
    Elias, Anthony D.
    Carvajal, Richard
    George, Thomas J.
    Yuan, Ying
    Yamamura, Yuko
    Westin, Shannon
    Xing, Yan
    Dumbrava, Ecaterina E. Ileana
    Karp, Daniel D.
    Piha-Paul, Sarina A.
    Tsimberidou, Apostolia M.
    Rodon, Jordi
    Takebe, Naoko
    Kunos, Charles
    Lu, Karen
    Keyomarsi, Khanda
    Meric-Bernstam, Funda
    CANCER RESEARCH, 2021, 81 (13)
  • [27] ADAGIO: a phase IIb international study of the Wee1 inhibitor adavosertib in women with recurrent or persistent uterine serous carcinoma
    Liu, Joyce
    Oza, Amit M.
    Colombo, Nicoletta
    Oaknin, Ana
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2022, 32 (01) : 89 - 92
  • [28] WEE1 Inhibitor Adavosertib Exerts Antitumor Effects on Colorectal Cancer, Especially in Cases with p53 Mutations
    Ariyoshi, Misa
    Yuge, Ryo
    Kitadai, Yuki
    Shimizu, Daisuke
    Miyamoto, Ryo
    Yamashita, Ken
    Hiyama, Yuichi
    Takigawa, Hidehiko
    Urabe, Yuji
    Oka, Shiro
    CANCERS, 2024, 16 (18)
  • [29] A phase II trial of the Wee1 inhibitor adavosertib (AZD1775) in recurrent uterine serous carcinoma.
    Liu, Joyce F.
    Xiong, Niya
    Campos, Susana M.
    Wright, Alexi A.
    Krasner, Carolyn N.
    Schumer, Susan T.
    Horowitz, Neil S.
    Veneris, Jennifer Taylor
    Tayob, Nabihah
    Morrissey, Stephanie
    West, Gabriela
    Quinn, Roxanne
    Matulonis, Ursula A.
    Konstantinopoulos, Panagiotis A.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [30] WEE1 kinase inhibitor shows promise
    Sidaway, Peter
    NATURE REVIEWS CLINICAL ONCOLOGY, 2019, 16 (10) : 593 - 593
12345